Abstract
Over a period of 5 years, lymphocyte subpopulations and their markers of activation were studied prospectively in 56 first degree relatives of Type 1 (insulin-dependent) diabetic probands. Lymphocytes were phenotyped using a panel of monoclonal antibodies which recognise CD3, CD4, CD8 lymphocytes, K/NK cells, HLA Class II products and IL-2 receptors (IL-2r). Twenty-six subjects were negative for islet cell antibody (ICA), 18 had complement fixing ICA (CF-ICA) and 12 only conventional ICA (ICA-IgG). The total number of observations (blood samples collected) was 386. Overall, changes in T cell data were observed in the three groups of first degree relatives compared to 70 normal subjects without a family history of diabetes. Six individuals developed Type 1 diabetes in the course of the study. They all possessed CF-ICA and five out of six showed a persistent reduction (less than 1.5) of the CD4/CD8 lymphocyte ratio before the clinical onset of the disease. Activated lymphocytes were found on two occasions in two of these subjects. We conclude that imbalance of lymphocyte immunoregulatory subsets is present before the onset of Type 1 diabetes in susceptible individuals; the persistence of a reduced CD4/CD8 lymphocyte ratio may ref...Continue Reading
References
Oct 1, 1987·Diabetologia·P PozzilliD Andreani
Feb 7, 1987·British Medical Journal·A C TarnE A Gale
Dec 1, 1986·Diabetes·C L HitchcockN K Maclaren
Mar 1, 1987·Diabetologia·D W Drell, A L Notkins
Jul 1, 1984·Diabetologia·P PozzilliG F Bottazzo
Apr 1, 1984·Diabetes·A R Hayward, M Herberger
Jan 1, 1983·Diabetes·P PozzilliA G Cudworth
Apr 1, 1980·Cell·E L Reinherz, S F Schlossman
Citations
Jan 28, 1998·American Journal of Primatology·J P CapitanioN W Lerche
Mar 1, 1991·Diabetes/metabolism Reviews·D AndreaniP Pozzilli
Jan 1, 1993·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·D L Faustman
Jun 1, 1991·Baillière's Clinical Endocrinology and Metabolism·P J Bingley, E A Gale
May 1, 1990·Diabetic Medicine : a Journal of the British Diabetic Association·M PeakmanD Vergani
Apr 23, 1994·BMJ : British Medical Journal·R Y TunR D Leslie
Dec 1, 1990·Postgraduate Medical Journal·A B Johnson, R Taylor
May 30, 2013·PloS One·Tanja ArndtDirk Wedekind
Jan 1, 2012·The Review of Diabetic Studies : RDS·Kate L GrahamThomas W H Kay
Jan 1, 1992·Acta Diabetologica·L al SakkafG F Bottazzo
Jan 1, 1993·Journal of Clinical Immunology·C GiordanoA Galluzzo
Jun 1, 2015·The Journal of Allergy and Clinical Immunology·Weijing HeSunil K Ahuja
Sep 10, 1999·Journal of Autoimmunity·B O RoepJ A Sachs
May 18, 2016·Journal of Diabetes Investigation·Juanjuan ZhangGuang Ning
Apr 11, 2003·Diabetologia·Bart O Roep
Nov 3, 2017·PLoS Pathogens·Joseph A McBride, Rob Striker
Aug 1, 1991·Clinical and Experimental Immunology·J IlonenM L Käär
Feb 1, 1994·Clinical and Experimental Immunology·E Di CesareD Cucinotta
Feb 9, 2019·Scientific Reports·Shahnawaz ImamJuan Carlos Jaume